BG
MDSO

Bahl & Gaynor’s Medidata Solutions, Inc. MDSO Stock Holding History

Bahl & Gaynor’s Portfolio MDSO Stock Details MDSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-39,498
Closed -$2.89M – 367
2019
Q1 		$2.89M Buy
39,498
+932
+2% +$67.3K 0.03% 182
2018
Q4 		$2.6M Sell
38,566
-2,971
-7% -$210K 0.03% 173
2018
Q3 		$3.04M Buy
41,537
+825
+2% +$66K 0.04% 170
2018
Q2 		$3.28M Buy
40,712
+828
+2% +$62.1K 0.03% 164
2018
Q1 		$2.5M Buy
39,884
+11,379
+40% +$757K 0.03% 187
2017
Q4 		$1.81M Buy
28,505
+7,279
+34% +$519K 0.02% 224
2017
Q3 		$1.66M Buy
21,226
+11,640
+121% +$886K 0.02% 220
2017
Q2 		$750K Buy
+9,586
New +$668K 0.01% 293

Other funds holding MDSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Bahl & Gaynor's MDSO Position: Q2 2019 in Review

Bahl & Gaynor sold out of Medidata Solutions, Inc. (MDSO) in Q2 2019, closing a stake of 39,498 shares — an estimated $2.89M sold.

Bahl & Gaynor first reported a position in MDSO in Q2 2017 and held it in 8 quarters. The position peaked at $3.28M in Q2 2018. 302 funds tracked by Wall St. Rank hold MDSO as of Q2 2019.

  • Bahl & Gaynor reported no remaining Medidata Solutions, Inc. position as of Q2 2019 after selling out during the quarter.
  • Bahl & Gaynor sold 39,498 Medidata Solutions, Inc. shares in Q2 2019, an estimated $2.89M.
  • Bahl & Gaynor first reported a position in Medidata Solutions, Inc. in Q2 2017 and held it in 8 quarters.
  • Bahl & Gaynor's Medidata Solutions, Inc. position peaked at $3.28M in Q2 2018.
  • 302 funds tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q2 2019.

Based on Bahl & Gaynor's 13F filing for Q2 2019, filed 12 Aug 2019.